Drugs / TIV2c
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT01992107 Comparator | Nov 2013 → Aug 2014 | influenza | Novartis Vaccines | Completed | Met primary |
| Phase 3 | NCT01992094 Comparator | Nov 2013 → Jul 2014 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV2c | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01992094 ↗ |
| Modality | Vaccine | “Novartis Investigational Vaccine” NCT01992094 ↗ |